Risk of Small Bowel Adenocarcinoma, Adenomas, and Carcinoids in a Nationwide Cohort of Individuals With Celiac DiseaseShow others and affiliations
2020 (English)In: Gastroenterology, ISSN 0016-5085, E-ISSN 1528-0012, Vol. 159, no 5, p. 1686-1694Article in journal (Refereed) Published
Abstract [en]
BACKGROUND & AIMS: The incidence of small bowel cancers is increasing. Associations have been made between celiac disease (CD) and small bowel cancers, but there have been no detailed studies of large cohorts.
METHODS: Through the nationwide Epidemiology Strengthened by Histopathology Reports in Sweden cohort study, we retrieved data from Sweden's 28 pathology departments on all individuals who received a diagnosis of CD from 1965 through 2017. Individuals with CD, defined as duodenal or jejunal villous atrophy (stage 3 Marsh score), were matched with as many as 5 randomly selected reference individuals from the general population. We used stratified Cox regression to calculate hazard ratios (HRs) for small bowel adenocarcinoma, adenomas, and carcinoids.
RESULTS: During a median follow-up of 11 years, we identified 48,119 individuals with CD (patients) and 239,249 reference individuals. Beginning at 1 year after a diagnosis of CD, 29 patients (0.06%) received a diagnosis of small bowel adenocarcinoma vs 45 reference individuals (0.02%), 7 patients received a diagnosis of carcinoids vs 31 reference individuals, and 48 patients received a diagnosis of adenomas vs 50 reference individuals. Corresponding HRs were small bowel adenocarcinoma 3.05 (95% confidence interval [CI], 1.86-4.99), carcinoids 0.59 (95% CI, 0.16-2.10), and adenomas 5.73 (95% CI, 3.70-8.88). HRs were independent of sex and age. Overall, there was 1 extra case of small bowel adenocarcinoma in every 2944 patients with CD followed for 10 years. There was an inverse association between mucosal healing risk of future small bowel adenocarcinoma (HR, 0.18; 95% CI, 0.02-1.61), although the HR failed to attain statistical significance.
CONCLUSIONS: In an analysis of a nationwide pathology database in Sweden, we found the absolute risk of small bowel adenocarcinoma is low in individuals with CD. However, risks of small bowel adenocarcinoma and adenomas (but not carcinoids) are significantly increased in people with CD compared to people without this disease.
Place, publisher, year, edition, pages
American Gastroenterology Association Institute , 2020. Vol. 159, no 5, p. 1686-1694
Keywords [en]
Intestine, Neoplasm, Etiology, Gluten
National Category
Gastroenterology and Hepatology
Identifiers
URN: urn:nbn:se:oru:diva-88359DOI: 10.1053/j.gastro.2020.07.007ISI: 000591420700013PubMedID: 32679218Scopus ID: 2-s2.0-85094811878OAI: oai:DiVA.org:oru-88359DiVA, id: diva2:1517307
Funder
Swedish Research Council
Note
Funding Agency:
The Louis and Gloria Flanzer Philanthropic Trust
2021-01-132021-01-132021-01-13Bibliographically approved